Invitae to acquire YouScript and Genelex for $100m.

Invitae, a medical genetics company, agreed to acquire YouScript, a privately held clinical decision support and analytics platform, for $79m and Genelex, a privately held pharmacogenetic testing company, for $21m. "Adding pharmacogenetics to Invitae's services enables us to offer greater value to our existing customers and helps us expand into new customer types and clinical areas. Despite its broad utility, the incorporation of pharmacogenetic information into routine medical care has been slow. We believe that Invitae's business model and technological capabilities, combined with an offering designed for ease of use in supporting clinical care, can accelerate the use of pharmacogenetic information. This is an exciting next step in our mission to bring comprehensive genetic information into mainstream medical care," Sean George, Invitae Co-Founder and CEO.